Table 5 Five-year outcomes according to diabetes status and revascularization assignment
Clinical endpoint | No diabetes (n = 834) | Crude HR (95% CI) | Adjusted HR (95% CI) | Diabetes (n = 371) | Crude HR (95% CI) | Adjusted HR (95% CI) | P for interaction | ||
|---|---|---|---|---|---|---|---|---|---|
Culprit-only PCI (n = 422) | Staged PCI (n = 412) | Culprit-only PCI (n = 207) | Staged PCI (n = 164) | ||||||
MACCE | 150 (35.5) | 131 (31.8) | 0.643(0.507–0.815) | 0.638 (0.500–0.816) | 66 (31.9) | 62 (37.8) | 0.939 (0.662–1.331) | 0.986 (0.683–1.422) | 0.053 |
Cardiac death/MI/stroke | 64 (15.2) | 47 (11.4) | 0.529 (0.362–0.774) | 0.621 (0.419–0.921) | 23 (11.1) | 23 (14.0) | 1.042 (0.583–1.862) | 1.593 (0.846–3.000) | 0.013 |
All-cause death | 39 (9.2) | 41 (10.0) | 0.808 (0.520–1.257) | 1.281 (0.803–2.042) | 18 (8.7) | 14 (8.5) | 0.709 (0.350–0.434) | 0.876 (0.404–1.898) | 0.410 |
Cardiac death | 17 (4.0) | 20 (4.9) | 0.913 (0.476–1.753) | 1.650 (0.817–3.335) | 11 (5.3) | 8 (4.9) | 0.685 (0.274–1.717) | 0.840 (0.304–2.316) | 0.284 |
MI | 39 (9.2) | 19 (4.6) | 0.346 (0.199–0.601) | 0.358(0.200–0.641) | 10 (4.8) | 12 (7.3) | 1.339 (0.578–3.103) | 1.599 (0.663–3.858) | 0.005 |
Stroke | 12 (2.8) | 8 (1.9) | 0.517 (0.210–1.272) | 0.574 (0.231–1.426) | 6 (2.9) | 5 (3.0) | 0.878 (0.267–2.885) | 0.857 (0.248–2.964) | 0.610 |
Unplanned revascularization | 105 (24.9) | 82 (19.9) | 0.625 (0.466–0.837) | 0.532 (0.393–0.720) | 45 (21.7) | 43 (26.2) | 1.045 (0.687–1.590) | 1.038 (0.672–1.605) | 0.013 |